Sim Yookyeong Carolyn, Hwang Jong-Hyun, Ahn Kang-Min
School of Medicine, Ewha Womans University, Seoul, Korea.
Department of Oral and Maxillofacial Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
J Korean Assoc Oral Maxillofac Surg. 2019 Apr;45(2):83-90. doi: 10.5125/jkaoms.2019.45.2.83. Epub 2019 Apr 29.
This study evaluated the predictive factors for survival of patients with oral squamous cell carcinoma (OSCC) and investigated the overall and disease-specific survival (DSS) outcomes.
A total of 67 consecutive patients who underwent surgery for OSCC from January 2006 to November 2014 were included in this study. Patients were classified according to age, sex, pTNM stages, primary sites, smoking and alcohol drinking habits, depth of invasion, perineural and lymphovascular invasion, cell differentiation and postoperative radiotherapy. Kaplan-Meier methods were used to estimate the survival categorized by patient groups. Cox regression methods were used to investigate the main independent predictors of survival.
Nineteen patients died of OSCC during follow-up periods. Another five patients died of other diseases including lung adenocarcinoma (n=1), cerebral infarction (n=1), general weakness (n=2), and pneumonia (n=1). The tongue (n=16) was the most common site for primary origin, followed by buccal mucosa (n=15), mandibular gingiva (n=15), maxillary gingiva (n=9), floor of mouth (n=9), retromolar trigone (n=2), and palate (n=1). Eleven patients had pTNM stage I disease, followed by stage II (n=22) and stage IV (n=34). No patients had pTNM stage III disease in this study. The overall survival of all patients was 64.2% and the DSS was 71.6%. DSS of patients with stage I and II disease was 100%. Stepwise Cox regression showed the two predictors for DSS were pTNM stage (<0.0001, odds ratio=19.633) and presence of metastatic lymph nodes (=0.0004, odds ratio=0.1039).
OSCC has been associated with poor prognosis; however, there were improved survival outcomes compared with past studies. Advanced-stage disease and presence of metastatic lymph nodes were associated with poorer survival compared with early-stage OSCC and absence of neck node metastasis. Stage I and II OSCC were associated with excellent survival results in this study.
本研究评估口腔鳞状细胞癌(OSCC)患者生存的预测因素,并调查总生存和疾病特异性生存(DSS)结果。
本研究纳入了2006年1月至2014年11月期间连续67例行OSCC手术的患者。患者根据年龄、性别、pTNM分期、原发部位、吸烟和饮酒习惯、浸润深度、神经周围和淋巴管浸润、细胞分化及术后放疗进行分类。采用Kaplan-Meier方法估计按患者分组的生存情况。采用Cox回归方法调查生存的主要独立预测因素。
19例患者在随访期间死于OSCC。另外5例患者死于其他疾病,包括肺腺癌(n = 1)、脑梗死(n = 1)、全身衰弱(n = 2)和肺炎(n = 1)。舌(n = 16)是最常见的原发部位,其次是颊黏膜(n = 15)、下颌牙龈(n = 15)、上颌牙龈(n = 9)、口底(n = 9)、磨牙后三角(n = 2)和腭(n = 1)。11例患者为pTNM I期疾病,其次是II期(n = 22)和IV期(n = 34)。本研究中无患者为pTNM III期疾病。所有患者的总生存率为64.2%,DSS为71.6%。I期和II期疾病患者的DSS为100%。逐步Cox回归显示,DSS的两个预测因素为pTNM分期(<0.0001,比值比 = 19.633)和转移性淋巴结的存在(= 0.0004,比值比 = 0.1039)。
OSCC的预后较差;然而,与过去的研究相比,生存结果有所改善。与早期OSCC和无颈部淋巴结转移相比,晚期疾病和转移性淋巴结的存在与较差的生存相关。在本研究中,I期和II期OSCC的生存结果良好。